A biological advantage is that we are better able to fix the KM as a constant property of a certain tissue or tumor type under given conditions which are largely dictated by the discrete nature of the molecular determinants, such as the isotype of the glucose transporter, GLUT-1 versus GLUT-3, for example. This evidence concerns the gene SLC2A3 and neoplasm.